NCT04256083View on ClinicalTrials.gov

Metabolomic and Proteomic Profiles of Amniotic Fluid Embolism

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

June 24, 2021

Primary Completion Date

October 25, 2021

Study Completion Date

October 25, 2021

Conditions
Amniotic Fluid Embolism
Interventions
BIOLOGICAL

Biological analysis

Two blood samples of 4 ml each (total: 8 ml) for IGFBP1 assay and metabolic phenotyping and proteomic analysis.

Trial Locations (4)

67000

Service Anesthésie Réanimation CHU de Hautepierre, Strasbourg, Strasbourg

69004

Service d'anesthésie réanimation Hôpital de la Croix Rousse, Lyon

69310

Service d'anesthésie réanimation Centre Hospitalier Lyon-Sud, Pierre-Bénite

69500

Service Anesthésie réanimation - Centre Hospitalier Hôpital Femme Mère Enfant - Groupement Hospitalier Est - Hospices Civils de Lyon, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER